Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction

Area of Science:

• Pharmacology
• Cardiology
• Biotechnology

Background:

• Cardiovascular side effects are a major cause of drug development failures.
• Predictive assays for cardiotoxicity are essential for the pharmaceutical industry.
• Current methods often involve heterologous expression systems that lack physiological relevance.

Purpose of the Study:

• To evaluate the suitability of stem cell-derived cardiomyocytes for automated patch clamp systems.
• To assess the potential of these cells in predicting drug-induced cardiotoxicity.
• To establish a more physiologically relevant in vitro model for drug screening.

Main Methods:

• Utilized stem cell-derived cardiomyocytes for automated patch clamp recordings.
• Recorded cardiac ion currents and action potentials.
• Investigated the effects of reference compounds on ion channel activity and action potentials.

Main Results:

• Successfully recorded cardiac ion currents and action potentials in stem cell-derived cardiomyocytes.
• Demonstrated drug-induced modulation of cardiac action potentials using automated patch clamp.
• Confirmed the physiological relevance of stem cell-derived cardiomyocytes compared to single ion channel cell lines.

Conclusions:

• Stem cell-derived cardiomyocytes are well-suited for automated patch clamp screening.
• This approach enables cost-effective cardiotoxicity prediction in a relevant cellular model.
• The combined technology offers a valuable tool for early-stage drug safety assessment.